AstraZeneca Pharma Quarterly Results for Trading Insights

ASTRAZEN • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹116 Cr
QMarch 2025
Quarterly Results

AstraZeneca Pharma Quarterly Results Key Highlights

  • Revenue of ₹1,757 Cr in March 2025 (+0.0% vs March 2025, +32.1% vs March 2024)
  • Net Profit of ₹116 Cr in March 2025 (+0.0% vs March 2025, -28.4% vs March 2024)
  • EBITDA of ₹295 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 15.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹46.30 in March 2025 (+0.0% vs March 2025)

AstraZeneca Pharma Quarterly Results Analysis

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 2,048 1,757 1,330 1,029 820 16.6% -
Net Profit (₹ Cr) 199 116 162 99 62 - -
EBITDA (₹ Cr) 316 295 219 191 101 - -
EPS (₹) 79.70 46.30 64.60 39.70 24.60 - -
Operating Margin (%) 14.0% 15.0% 14.0% 16.0% 11.0% - -

AstraZeneca Pharma Share Price Trend Around Quarterly Results

Visualize AstraZeneca Pharma's 1-year price movement across quarterly results — ideal for logging trades in AstraZeneca Pharma share price chart using Tickjournal. All values in ₹.

Related Pages for AstraZeneca Pharma

Additional stock information and data for ASTRAZEN

ASTRAZEN shareholder distribution
AstraZeneca Pharma stock price data download
AstraZeneca Pharma P/B valuation
ASTRAZEN dividend growth
ASTRAZEN earnings multiple
ASTRAZEN share price history chart
ASTRAZEN complete financial

Profitability Ratios

Profit Margin 6.6%
EBITDA Margin 16.8%
Operating Margin 15.0%
ROE (Annual) 15.1%

Balance Sheet Highlights

Total Assets ₹1,518 Cr
Total Equity ₹770 Cr
Current Assets ₹1,342 Cr
Current Liabilities ₹45 Cr

Cash Flow Analysis

Operating Cash Flow ₹65 Cr
Investing Cash Flow ₹31 Cr
Financing Cash Flow ₹-66 Cr
Net Cash Flow ₹31 Cr

Current Market Data

Current Price ₹8464.50
Exchange NSE
Last Updated Jan 07, 2026

Revenue Trend (₹ Cr)

March 2023 1,029
March 2024 1,330
March 2025 1,757
2026 2,048

Net Profit Trend (₹ Cr)

March 2023 99
March 2024 162
March 2025 116
2026 199

Operating Margin Trend (%)

March 2023 16.0%
March 2024 14.0%
March 2025 15.0%
2026 14.0%

Sector Competitors - Quarterly Performance Comparison

Comparing AstraZeneca Pharma quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹422,330.94 Cr 1782.6 14,875 3,125 +10.8% - 21.0% 137.1
Divis Laboratories
Sept 2025 		₹176,337.50 Cr 6642.5 2,860 689 +7.1% - 24.1% 255.8
Torrent Pharmaceuti…
Sept 2025 		₹136,522.12 Cr 4092.2 3,219 591 +11.3% - 18.4% 233.3
Cipla
Sept 2025 		₹121,238.47 Cr 1467.9 7,716 1,353 +12.0% - 17.5% 87.7
Dr Reddys Laborator…
Sept 2025 		₹104,829.57 Cr 1242.8 9,135 1,337 +1.1% - 14.6% 76.8
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores